The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice

Blood

Volumn 127, Issue 13, 2016, Pages 1676-1686

  Zhang, Zubin ^a   Tong, Jiefei ^b   Tang, Xiaowen ^c   Juan, Jiaxiang ^a   Cao, Biyin ^a   Hurren, Rose ^d   Chen, Guodong ^a   Taylor, Paul ^b   Xu, Xin ^a   Shi, Chang Xin ^e   Du, Juan ^f   Hou, Jian ^f   Wang, Guanghui ^a   Wu, Depei ^c   Stewart, A Keith ^e   Schimmer, Aaron D ^d   Moran, Michael F ^b   Mao, Xinliang ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c SOOCHOW UNIVERSITY   (China)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e MAYO CLINIC   (United States)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; DEUBIQUITINASE; DEUBIQUITINASE USP5; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR MAFA; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE HERC4; UNCLASSIFIED DRUG; HERC4 PROTEIN, MOUSE; MAF PROTEIN, MOUSE; UBIQUITIN;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PURIFICATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOLECULAR WEIGHT; MOUSE; MULTIPLE MYELOMA; MULTIPLE MYELOMA CELL LINE; NCI-60 CELL LINE; NIH 3T3 CELL LINE; NONHUMAN; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RPMI 8226 CELL LINE; TANDEM MASS SPECTROMETRY; TRANSACTIVATION; TUMOR XENOGRAFT; UBIQUITINATION; 3T3 CELL LINE; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; HELA CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; XENOGRAFT;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; HEK293 CELLS; HELA CELLS; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; MICE, SCID; MULTIPLE MYELOMA; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; PROTO-ONCOGENE PROTEINS C-MAF; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84982102800     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-07-658203     Document Type: Article

References (28)

1. Eychène A, Rocques N, Pouponnot C. A new MAFia in cancer. Nat Rev Cancer. 2008;8(9):683-693.
2. Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators? J Mol Biol. 2008;376(4):913-925.
3. Sato K, Miyoshi F, Yokota K, et al. Marked induction of c-Maf protein during Th17 cell differentiation and its implication in memory Th cell development. J Biol Chem. 2011;286(17):14963-14971.
4. Mao X, Zhu X, Hurren R, Ezzat S, Schimmer AD. Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cells. Leuk Res. 2008;32(9):1480-1482.
5. Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: clinical applications. Blood. 2004;104(3):607-618.
6. Morito N, Yoh K, Fujioka Y, et al. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res. 2006;66(2):812-819.
7. Hurt EM, Wiestner A, Rosenwald A, et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell. 2004;5(2):191-199.
8. Chen G, Xu X, Tong J, et al. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues. Int J Biochem Cell Biol. 2014;57:157-166.
9. Mao X, Stewart AK, Hurren R, et al. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin. Blood. 2007;110(12):4047-4054.
10. Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem. 2002;277(51):49903-49910.
11. Mao X, Hou T, Cao B, et al. The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence. Mol Pharmacol. 2011;79(4):672-680.
12. Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF. Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS One. 2013;8(6):e64817.
13. Mao X, Cao B, Wood TE, et al. A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway. Blood. 2011;117(6):1986-1997.
14. Krönke J, Udeshi ND, Narla A, et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science. 2014;343(6168):301-305.
15. Lu G, Middleton RE, Sun H, et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science. 2014;343(6168):305-309.
16. López-Corral L, Corchete LA, Sarasquete ME, et al. Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies. Haematologica. 2014;99(8):1365-1372.
17. Pfister TD, Reinhold WC, Agama K, et al. Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther. 2009;8(7):1878-1884.
18. Hochrainer K, Mayer H, Baranyi U, Binder B, Lipp J, Kroismayr R. The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. Genomics. 2005;85(2):153-164.
19. Rodriguez CI, Stewart CL. Disruption of the ubiquitin ligase HERC4 causes defects in spermatozoon maturation and impaired fertility. Dev Biol. 2007;312(2):501-508.
20. Zeng WL, Chen YW, Zhou H, Zhou JY, Wei M, Shi R. Expression of HERC4 in lung cancer and its correlation with clinicopathological parameters. Asian Pac J Cancer Prev. 2015;16(2):513-517.
21. Zhou H, Shi R, Wei M, Zheng WL, Zhou JY, Ma WL. The expression and clinical significance of HERC4 in breast cancer. Cancer Cell Int. 2013;13(1):113.
22. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 2002;21(15):4037-4048.
23. Xu K, Shimelis H, Linn DE, et al. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell. 2009;15(4):270-282.
24. Lin BS, Tsai PY, Hsieh WY, et al. SUMOylation attenuates c-Maf-dependent IL-4 expression. Eur J Immunol. 2010;40(4):1174-1184.
25. Leavenworth JW, Ma X, Mo YY, Pauza ME. SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4. J Immunol. 2009;183(2):1110-1119.
26. Mahoney KM, Petrovic N, Schacke W, Shapiro LH. CD13/APN transcription is regulated by the proto-oncogene c-Maf via an atypical response element. Gene. 2007;403(1-2):178-187.
27. Lai CY, Lin SY, Wu CK, Yeh LT, Sytwu HK, Miaw SC. Tyrosine phosphorylation of c-Maf enhances the expression of IL-4 gene. J Immunol. 2012;189(4):1545-1550.
28. Herath NI, Rocques N, Garancher A, Eychène A, Pouponnot C. GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target. Blood Cancer J. 2014;4:e175.